A New 340,000-Person Drinking Study Will Get Misquoted by Friday. Here’s What It Actually Found.

By the time this study finishes circulating on social media, it will have been reduced to a single headline: wine is good for your heart. That headline is not wrong so much as it is doing more work than the data can carry — and the gap between what the study found and what people will say it found is, itself, the story.

The finding that will survive contact with a group chat by Friday is true and useless on its own: how much you drink matters more than what you drink, and past a certain point, nothing you’re drinking is doing you any favors.

What the study actually did

Researchers at Central South University’s Xiangya Hospital, led by Dr. Zhangling Chen, followed 340,924 adults in the UK Biobank cohort from 2006 to 2022 — an average of more than 13 years per person — tracking both how much people drank and which beverage they favored: beer, wine, spirits, or cider. The results were presented at the American College of Cardiology’s 2026 scientific session and covered by ScienceDaily on August 8. This is an observational cohort study, not a randomized trial — a distinction that matters more here than almost anywhere else in this article, and one the researchers themselves lead with in their own caveats.

The part that isn’t in dispute

Heavy drinkers — defined as more than 40 grams of alcohol a day for men and more than 20 grams for women, roughly three or more standard drinks daily — had a 24% higher risk of dying from any cause than people who drank never or rarely, regardless of what they drank. Their cancer mortality risk was 36% higher. Their cardiovascular mortality risk was 14% higher. Beer drinker, wine drinker, spirits drinker: past the heavy-drinking line, the beverage stopped mattering and the volume took over. If you remember nothing else from this study, remember that part — it’s the part with no asterisk.

The part that will get flattened into a headline

Below the heavy-drinking threshold, the data split in a way that’s genuinely interesting and genuinely easy to misuse. Moderate wine drinkers had a 21% lower cardiovascular mortality risk compared to people who didn’t drink at all. Moderate beer, spirits, and cider drinkers, by contrast, had a 9% higher cardiovascular mortality risk than abstainers. Same alcohol content, opposite direction of association, and that’s exactly the kind of result that gets stripped of its caveats on the way to a wine-brand Instagram post.

Here’s the caveat, stated plainly instead of buried: this is an association, not a mechanism, and the researchers say so themselves. People who choose wine in a UK Biobank-style cohort tend to differ from people who choose beer or spirits in ways that have nothing to do with alcohol — higher income, more education, healthier diets on average, wine consumed with meals rather than separately from them. Those are exactly the variables that predict lower cardiovascular mortality on their own, with or without a glass of Cabernet attached. A study can statistically adjust for income and diet and still not fully capture the difference between someone who treats a nightly glass of wine as a ritual embedded in a broader pattern of care for themselves, and someone who doesn’t. That gap is where “wine is heart-healthy” quietly stops being a finding and starts being a story people want to be true.

Why this lands differently than the last wave of alcohol research

This study arrives less than a year after a wave of research pointing the other direction. STAT News’s “Deadliest Drug” investigative series, which ran through July 2026, put alcohol’s US death toll at roughly 178,000 a year and argued the country tracks and taxes it like a background risk factor rather than the parallel epidemic the numbers describe — a framing that lines up with how the CDC’s own overdose and mortality tracking has started treating substance-related mortality generally. Clinicians are increasingly being told to stop reflexively recommending “a glass of red wine a day” as preventive cardiology. Nothing here reverses that. A 24% jump in all-cause mortality at the heavy-drinking threshold, cancer risk up more than a third, is not a study that lets moderate-to-heavy drinkers off the hook. It’s a study about the shape of the curve below that threshold, where most drinkers actually live, and about how thin the evidence is for treating any specific beverage as protective rather than merely correlated with a healthier life around it.

Clinicians are increasingly being told to stop reflexively recommending “a glass of red wine a day” as preventive cardiology.

That distinction matters clinically, too. Researchers elsewhere are actively testing whether reducing alcohol intake through other mechanisms — a Lancet-published trial of once-weekly semaglutide found a roughly 41% drop in heavy-drinking days among people with alcohol use disorder and obesity, compared to about 26% on placebo — moves the same mortality needles this Biobank study is measuring, without any beverage-type variable to muddy the picture. That’s a cleaner signal than “drink wine instead of beer,” and one Rize covers in more depth in today’s alcohol harm-reduction spotlight.

If you’re a clinician fielding the inevitable “but I read that wine is good for you” question this week, the honest answer is short: heavy drinking is dangerous regardless of what’s in the glass, moderate wine drinkers in this cohort did better than moderate beer or spirits drinkers, and nobody has isolated why closely enough to write a prescription around it. Say that, not the headline.

Full coverage of alcohol research lives on Rize’s alcohol substance hub and in our science & medicine coverage.